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DObjective: To update the current evidence on mitral valve surgery through a lateral minithoracotomy versus
median sternotomy.
Methods: A comprehensive literature research was performed for studies comparing mitral valve surgery
through a right lateral minithoracotomy (MIVS) and median sternotomy in MEDLINE, EMBASE, Cochrane
Central, CTSnet, and Google Scholar for the most recent literature up to April 2013. A systematic review
and meta-analysis was performed on the studies found in the literature.
Results: More than 20,000 patients from 45 studies were included in this study. Stroke rate and all-cause
mortality up to 30 days was similar in both groups. The length of stay in the intensive care unit, respirator
dependence, and hospital stay were significantly shorter in the MIVS group. Furthermore, blood drainage
volume and blood transfusions were decreased in the MIVS group. In contrast, cardiopulmonary bypass
time, crossclamp time, and procedure time were longer in the MIVS group. Postoperative new atrial fibrillation
was less in the MIVS group. More aortic dissections occurred in the MIVS group. The rates of reexploration and
postoperative renal failure were similar in both groups.
Conclusions: MIVS and conventional mitral valve surgery have a similar perioperative outcome. Mitral
valve surgery via a right lateral minithoracotomy seems to be favorable with regard to resource-related outcome.
(J Thorac Cardiovasc Surg 2014;148:1989-95)Supplemental material is available online.
Right lateral minithoracotomy has become the standard
approach for mitral valve surgery in many centers and is
considered to be minimally invasive (MIVS) access. There
is still ongoing debate about the benefits of minimally
invasive interventions. Several studies as well as 2
meta-analyses comparing conventional surgery (CS) and
minimally invasive surgery are available in the literature.
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The Journal of Thoracic and Carwith MIVS. This study contradicts the meta-analysis
presented by Modi and colleagues.2 Because of these
conflicting results and the recent literature now available,
we performed a systematic review and meta-analysis to
update the current evidence.
The objective of this systematic review andmeta-analysis
was to determine the outcome of patients treated either
minimally invasively through a right lateral minithoraco-
tomy or conventionally via a median sternotomy. Mortality
and neurologic outcome were the main interest. In addition,
procedure- and resource-related outcomes were assessed.
METHODS
A systematic review and meta-analysis of comparative studies was
performed in accordance with the methodological recommendations by
PRISMA (Preferred Reporting Items for Systematic Reviews) andMOOSE
(Meta-Analysis of Observational Studies in Epidemiology) for randomized
and observational studies.3,4 Outcomes, search strategies, inclusion
criteria, and statistical analysis were predefined before the literature
research.
End Points
End points were defined as 30-day mortality, stroke, postoperative
myocardial infarction, new onset of atrial fibrillation, new renal insuffi-
ciency, perioperative aortic dissection, rethoracotomy for bleeding, need
for blood transfusion, blood drainage volume, procedure time, crossclamp
time, cardiopulmonary bypass (CPB) time, length of hospital stay, length of
intensive care unit (ICU) stay, length of respirator dependence, and costs.
Literature Research
A comprehensive literature search was performed in MEDLINE,
EMBASE, Cochrane CENTRAL, CTSnet, and Google Scholar from thediovascular Surgery c Volume 148, Number 5 1989
Abbreviations and Acronyms
CI ¼ confidence intervals
CPB ¼ cardiopulmonary bypass
CS ¼ conventional surgery
ICU ¼ intensive care unit
MIVS ¼ minimally invasive surgery
RR ¼ risk ratio
WMD ¼ weighted mean difference
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D earliest possible date until April 2013. Search terms were ‘‘mitral valve
surgery,’’ ‘‘robotic surgery,’’ ‘‘port access surgery,’’ ‘‘thoracoscopic sur-
gery,’’ ‘‘minimally invasive surgery,’’ ‘‘sternotomy,’’ and variants and
combinations of these keywords. The search was performed without
any limits with regard to publication date, study design, or language.
References from reviews were for manually searched for relevant articles.
Experts were asked for further literature or unpublished data.
Inclusion Criteria
Randomized or nonrandomized studies comparing mitral valve
surgery (repair or replacement) via a right lateral minithoracotomy
(with or without camera support, with or without robotic support) versus
sternotomy (through a complete median sternotomy) were included.
Exclusion Criteria
Studies including mainly redo surgical procedures were excluded.
The cause of the mitral valve disease was not taken into consideration
for inclusion or exclusion of the studies.
Data Analysis
For baseline characteristics, weighted mean differences or risk ratios
were calculated to describe differences between the groups. When
significant heterogeneity was seen in the Q statistics (I2> 60%), the
random effects model was used. Otherwise, the fixed effects model was
used. In the meta-analysis, risk ratios (RRs) and 95% confidence intervals
(CIs) were calculated for end points with discrete data. For continuous data,
weighted mean differences (WMD) and 95% CIs were calculated. The
Q statistic was used to calculate heterogeneity (I2). RR and WMD were
calculated using the random effects model when significant heterogeneity
was present (I2>60%). Statistical significance was defined as P<.05 or a
confidence interval that excluded the value 1.00 for RR and 0 for WMD.
The meta package in R was used for the meta-analysis as described by
Guido Schwarzer in 2012 (meta: Meta-Analysis with R. R package version
2.1-1; available at: http://cran.r-project.org/web/packages/meta/meta.pdf).
RESULTS
Study Identification
The initial search in the different databases resulted in
more than 3400 records. Almost 3000 records were
excluded immediately because of description of irrelevant
data. After exclusion of these records, 504 papers were
retrieved for full review. Forty-one articles included studies
that met the inclusion criteria for the comparison of
MIVS versus CS5-45 (Figure 1). In 4 articles,11,26,35,42
different studies within the same article were identified,
resulting in a total of 45 studies. Three studies9,10,40 were
prospectively randomized; the rest of the studies were1990 The Journal of Thoracic and Cardiovascular Surnonrandomized and mainly retrospective. Six of these
were propensity score matched.14,17,21,22,28,38 The studies
were published between 1997 and 2013 mainly from the
United States (22), followed by Germany (6), China (2),
France (2), Slovenia (2), and 1 study each from Egypt,
Serbia, Brazil, Israel Austria, India, and Italy.
Crossclamping was predominantly performed; endoaortic
balloon occlusion was performed in only 19
studies.5,6,9,15,16,18-20,26,28,29,32,33,35,36,3,42 In 16 studies,
direct transthoracic crossclamping was predominantly
used.7,8,10-12,21-24,30,34,40,41,45 In the rest of the studies
(n ¼ 11), both modalities were used in the same
proportion or it was not clearly stated which technique
was mainly used.Baseline Characteristics
The baseline characteristics are summarized in Table 1. A
total of 20,342 patients were represented in the studies.
MIVS was performed in 11,088 patients and CS was
performed in 9254 patients. Patients in the MIVS group
were younger on average by 1.7 years (57.3  9.3 years
vs 58.6  9.6 years). Body mass index was lower in the
MIVS group on average by 0.54 kg/m2 (25.7  2.8 kg/m2
vs 26  2.5 kg/m2). Fewer patients had renal failure (RR,
0.23) in the MIVS group. Left ventricular ejection fraction
was better in the MIVS group on average by 1.3% (55.8%
 7.3% vs 54.9% 8.1%). Other risk factors did not differ
significantly. More patients had a mitral valve repair in the
MIVS group (82% vs 75%; RR, 1.2; (95% CI, 1.0-1.5) in
the random effects model (I2 ¼ 95%); P ¼ .04).All-Cause Mortality
All-cause mortality was described in 29 studies with a
total of 18,019 patients.7,9,10,12-14,16,17,19-25,27,28,30,32,34,35,37,
38,40,41,43-45 All-cause mortality up to 30 days was 1.6% and
did not differ significantly between patients treated with
MIVS or CS (1.4% vs 1.7%, respectively). There was no
significant heterogeneity among the studies for this
outcome (I2 ¼ 36%), thus the fixed effects model was
used (RR, 0.79; 95% CI, 0.63-0.99; P ¼ .04). The linear
regression test showed no asymmetry in a funnel plot
(P>.2). The results are illustrated in Figure 2.Stroke
Total stroke rate was 1.7% (n ¼ 18 studies) in 14 390
patients.7,11,14,17,19,21-24,27,28,30,32,38,40,41 There was no
significant difference with regard to stroke rate between
groups (1.7% in the MIVS group vs 1.6% in the CS
group). There was significant heterogeneity among the
studies (I2 ¼ 60%; P ¼ .012). The risk ratio in the
random effects model was 0.68 (95% CI, 0.39-1.20). The
linear regression test of funnel plot asymmetry showed
significant asymmetry (P ¼ .012) (Figure 3).gery c November 2014
FIGURE 1. Study flowchart.
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DA subanalysis was performed for those studies in
which mainly endoaortic balloon occlusion or transthoracic
crossclamping was used.5,6,9,15,16,18-20,26,28,29,32,33,35,36,38,42
There was a clear difference between the groups. In the
analysis of studies in which a transthoracic crossclamp
was used for both groups, the results showed a decreased
stroke rate in patients with minimally invasive procedures
(I2 ¼ 0%; fixed effects model RR, 0.39; 95% CI,
0.24-0.61; P< .001). In the studies in which endoaortic
balloon occlusion was used in the MIVS group, the
results were in favor of conventional sternotomy
(I2 ¼ 0%; fixed effect model RR, 1.89; 95% CI,
0.87-4.14; P>.2).Other End Points
All other end points are summarized in Table 2.
Procedure time (Figure E1), CPB time (Figure E2), and
crossclamp time (Figure E3) were longer in the MIVS
group. Blood drainage volume (Figure E4) and need for
blood transfusion (Figure E5) was reduced in the MIVSTABLE 1. Baseline characteristics of the patients
n (N) MIVS
Age, y  SD 33 (10,454) 57.0  9.6
Female,% 31 (15,717) 49
LVEF,%  SD 20 (14,247) 55.8  7.3
Mitral stenosis,% 11 (1803) 15
Mitral regurgitation (degenerative),% 11 (1950) 82
BMI, kg/m2  SD 6 (2702) 25.7  2.8
Diabetes,% 13 (12,466) 8
CVD,% 9 (12,625) 9
HT,% 7 (11,328) 57
AFIB,% 9 (9765) 21
Renal insufficiency,% 3 (1373) 0.6
COPD,% 7 (10,718) 10
n, Number of studies; N, total number of patients; MIVS, minimally invasive surger
WMD, weighted mean difference; RR, risk ratio; I2, test of heterogeneity (when I2 was>
used); CI, confidence interval; SD, standard deviation; LVEF, left ventricular ejection fract
AFIB, atrial fibrillation; COPD, chronic obstructive pulmonary disease.
The Journal of Thoracic and Cargroup as well as length of ICU stay (Figure E6), length of
respirator dependence (Figure E7), and length of hospital
stay (Figure E8). The rate of rethoracotomies (Figure E9)
was similar in both groups as well as the rate of new onset
of atrial fibrillation (Figure E10) and new postoperative
renal failure (Figure E11). Aortic dissection was recorded
for only 4 patients in the MIVS group. Total costs were
less in the MIVS group.
DISCUSSION
In this systematic review and meta-analysis, we aimed to
include the current literature comparing MIVS performed
via a right lateral thoracotomy and CS performed via a
median sternotomy of the mitral valve to determine
differences in the outcome.
The main differences between the procedures were found
for procedure- and resource-related outcomes. In the
discussion about the optimal access for mitral valve surgery,
these outcomes are often used to argue for or against one or
the other procedure. In this context, we assessed CPB time,
crossclamp time, procedure time, length of hospital stay,
ICU stay as well as other factors. In line with previous
reports, we found that CPB time, crossclamp time, and
procedure time were increased in the MIVS group. In
contrast, length of ICU stay, respirator dependence, and
length of hospital stay were significantly reduced. Few
studies calculated and compared costs for both procedures
and it seems that minimally invasive procedures cumulate
fewer costs than conventional procedures. However,
because of the low number of studies on this issue, a general
assertion cannot be made. These findings are also in
accordance with previous meta-analyses.1,2
For perioperative outcome, 30-day mortality and stroke
ratewere the main interest. This was mainly due to the study
presented by Cheng and colleagues,1 in which the reported
stroke rate was alarming high in the MIVS group.CS WMD or RR (95% CI) P I2 (%)
58.4  9.8 1.7 (2.3 to 1.1) <.001 95
47 1.0 (0.9 to 1.1) >.2 82
54.9  8.1 1.3 (0.3 to 2.2) .01 99
16 0.98 (0.80 to 1.20) >.2 0
79 1.02 (0.99 to 1.05) >.2 62
26  2.5 0.54 (0.89 to 0.19) .003 99
8 0.95 (0.69 to 1.32) >.2 64
9 0.66 (0.41 to 1.1) .08 90
50 1.00 (0.97 to 1.04) >.2 0
22 0.97 (0.90 to 1.05) >.2 30
2.8 0.23 (0.08 to 0.63) .005 0
11 0.90 (0.80 to 1.00) .07 47
y, right lateral minithoracotomy; CS, conventional surgery, midline sternotomy;
60%, the random effects model was used, otherwise the fixed effects model was
ion; BMI, body mass index; CVD, cerebrovascular disease; HT, arterial hypertension;
diovascular Surgery c Volume 148, Number 5 1991
FIGURE 2. Forest and funnel plots for all-cause mortality up to 30 days. MIV, Minimally invasive; Conv, conventional; RR, risk ratio; CI, confidence
interval; W, weight.
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which is in line with 2 previously published meta-analyses.
Cheng and colleagues1 raised the issue that the large,
propensity-matched analysis from Gammie and colleagues14
shows a significant increase in the composite end point of
major hospitalmorbidity (defined as the need for reoperation,
deep sternal wound infection, stroke, renal failure, or pro-
longed ventilation or both) and mortality in the MIVS group
leading to potential concern about the safety of minimally
invasive procedures. Unfortunately, in newer propensity-
matched or prospective studies since the meta-analysis
from Cheng and colleagues,1 this combined end point is
not assessed. One prospective, randomized controlled trialFIGURE 3. Forest and funnel plots for stroke rate. MIV, Minimally invasive
1992 The Journal of Thoracic and Cardiovascular Surand 1 propensity-matched analysis, both from 2011,21,40
show higher mortality in the MIVS group. The event rate is
low in both studies. The single end points, which were
combined in the composite end point in the publication by
Gammie and colleagues,14 all show results in favor of mini-
mally invasive procedures in newer publications. One excep-
tion is the rate of reoperation for bleeding in the publication
by Goldstone and colleagues17 from 2013 showing a 5-fold
higher rate of rethoracotomies in the MIVS group (2.5%
vs 0.5%); however the reasons are not explained. The 30-
day mortality within all studies is low at 1.5%.
Stroke rate was low and similar in both groups (1.7% vs
1.6%). These results are in contrast to the meta-analysis; Conv, conventional; RR, risk ratio; CI, confidence interval; W, weight.
gery c November 2014
TABLE 2. Secondary end points
n (N) References MIVS CS WMD or RR (95% CI) P I2 (%)
FPA
(P)
Procedure time,
minutes  SD
(Figure E1)
13 (1469) 6,8-12,16,21,33,40,43,44 258  41.8 210.7  34.4 51.6 (26.2 to 77) <.001 99 >.2
CPB time,
minutes  SD
(Figure E2)
28 (5609) 5-7,8-12,15-18,21-24,26,30,33,34,36,
38,40,43-45
142.6  26.5 107.7  25.2 36.6 (31.2 to 41.9) <.001 99 .08
Crossclamp time,
minutes  SD
(Figure E3)
30 (5953) 5-7,8-12,15-19,21-24,26,30,33-38,40,
43-45
93.7  31.3 74.2  27.5 19.4 (13.7 to 25) <.001 99 .13
Blood drainage
volume, mL  SD
(Figure E4)
10 (1322) 5,7,9-12,16,40,43 674  288 775  292 142.1 (199.2 to 85.1) <.001 96 >.2
Need for transfusion,
% (Figure E5)
12 (12,243) 7,9,11,12,14,17,28,38,40,41 37 45 0.67 (0.51 to 0.88) .004 93 .19
LOS ICU,
hours  SD
(Figure E6)
16 (1717) 5-7,8,9,11,12,27,30,33,35,36,40,45 44  30 66  47 19.4 (27.1 to 11.6) <.001 97 >.2
Respirator dependence,
hours  SD
(Figure E7)
16 (2583) 5,6,8,10,11,16,26,32,34,35,37,38,42,44 12.3  11.2 22.3  29.1 8.7 (14 to 3.4) .001 99 >.2
LOS in hospital,
days  SD
(Figure E8)
27 (4948) 5-8,10,11,16,17,21-24,27,30-38,40,45 7.6  3.2 9.4  3.4 2.0 (2.4 to 1.5) <.001 99 >.2
Rethoracotomy,
% (Figure E9)
22 (15,265) 7,9,11,12,14,17,21-24,26,28,32,34,35,
38,40,41,43,45
3.8 3.2 1.14 (1.0 to 1.3) .13 13 .08
Aortic dissection, no. 5 (9823) 14,18,21,32,38 4 0 8.2 (1.0 to 65.2) .05 0 —
New AF,%
(Figure E10)
11 (3646) 6,7,16,17,21,28,30,33,38,41 25 29 0.9 (0.8 to 1.0) .07 48 >.2
New renal insufficiency,
% (Figure E11)
11 (11,346) 7,11,14,17,21-24,32,40 2.1 2.1 1.0 (0.8 to 1.3) 1 60 .02
Costs (US$) 3 (756) 23-25 35,135  1702 42,742  2712 7594.3 (15,928 to 739) .07 99 —
n, Number of studies; N, total number of patients; MIVS, minimally invasive surgery, right lateral minithoracotomy; CS, conventional surgery, midline sternotomy;
WMD, weighted mean difference; RR, risk ratio; CI, confidence interval; I2, test of heterogeneity (when I2 was>60%, the random effects model was used, otherwise the fixed
effects model was used); FPA, funnel plot asymmetry; SD, standard deviation; CPB, cardiopulmonary bypass; LOS, length of stay; ICU, intensive care unit; AF, atrial fibrillation.
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number of newer studies, in which all reported
stroke rates are in favor of MIVS.17,23,24,27,40,41 A
reason could be that MIVS mitral valve surgery has
evolved in terms of technology and surgeon experience,
therefore challenges like deairing and worse exposure
have been overcome. We also performed a subanalysis
of studies that exclusively used endoaortic balloon
occlusion or a transthoracic crossclamp in the MIVS
group. Studies from centers where MIVS procedures are
performed mainly with the use of the endoaortic balloon
occlusion5,6,9,15,16,18-20,26,28,29,32,33,35,36,38,42 reported
stroke rates in favor of mitral valve CS. This is in
contrast to studies from centers where the transthoracic
aortic crossclamp was used predominantly.7,8,10-12,21-
24,30,34,40,41,45 These studies were obviously in favor of
MIVS. From these data, it can be hypothesized that aortic
balloon occlusion has an impact on neurologic outcome.
In this context, it might be of great interest to conductThe Journal of Thoracic and Carfurther studies that specifically investigate differences
with regard to this particular outcome. There is strong
asymmetry in the funnel plot for stroke indicating a study
bias for this end point. Therefore, this result has to be
viewed with caution.
We also assessed the impact of thoracic access with re-
gard to blood loss, need for blood transfusion, and drainage
volume. Blood drainage volume was significantly less
(about 142 mL) in the MIVS group as might be assumed,
with the argument that the smaller operative field leads to
less need for blood transfusion. Accordingly, the need for
blood transfusion was less in the MIVS group. The need
for rethoracotomy because of bleeding complications did
not differ significantly between both groups. Perioperative
outcomes such as postoperative renal insufficiency, atrial
fibrillation, and aortic dissections were also assessed. Our
meta-analysis showed no difference between the groups
for renal insufficiency or the rate of postoperative atrial
fibrillation. The rate of aortic dissection was significantlydiovascular Surgery c Volume 148, Number 5 1993
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tions was low. In those publications reporting a
higher incidence of aortic dissection in the MIVS group
(1 was a propensity-matched study with a high number of
patients14), no conclusive explanation could be offered for
these findings. In all these studies except 1, in which both
aortic clamping techniques were used, endoaortic balloon
occlusion was used. This might be a potential explanation
but is totally hypothetical and must be confirmed or
dismissed by further studies.
Another finding of our meta-analysis is that minimally
invasive access is not associated with a lower number of
mitral valve repairs. The number of mitral valve repairs
compared with mitral valve replacements was higher in
the MIVS group. Selection bias or different experience
levels could explain this result.
Our meta-analysis has several limitations. First, the
quality of all meta-analysis is limited by the studies that
are included. For this meta-analysis, mainly retrospective
studies were found. Only few were propensity
matched,14,17,21,22,28,38 and thus similar to prospective
randomized trials. The comparator in some studies was a
historical group of patients treated via sternotomy11,33
because thoracotomy has become the standard access and
thus no actual control group treated through a sternotomy
was available. It also cannot be excluded that there was
significant data overlap for some studies, with data from
overlapping patient cohorts reported at different points of
time; for example, the 3 studies from Iribarne and
colleagues.22-24 Also, reporting from outcome data varied
throughout the studies. It also cannot be excluded that
patients who were included in the Society of Thoracic
Surgeons database analysis by Gammie and colleagues14
are the same as those included in smaller studies in the
United States. This has been broadly discussed in the
meta-analysis by Cheng and colleagues.1 The authors
concluded that this did not have any significant impact on
the conclusion because of the large weight of the study by
Gammie and colleagues14 compared with the other studies.
The newer studies that are included in this meta-analysis are
not included in any larger database analysis. Another factor
in every study that compares different techniques and can
bias the results, is that different techniques are more likely
to be performed by different surgeons and not by 1 single
surgeon. But this is not described in most of the studies
included. We also did not address the underlying cause
of the mitral valve disease. A recent meta-analysis46
did so comparing lateral minithoracotomy and median
sternotomy for mitral valve surgery in patients with
degenerative mitral valve disease. The results are in
accordance with ours; no significant differences in
clinical end points such as mortality, cerebrovascular
accidents, and others were found. Because of these1994 The Journal of Thoracic and Cardiovascular Surlimitations, meta-analyses cannot replace prospective
randomized trials.
In conclusion, this meta-analysis showed that periopera-
tive outcome is similar for minimally invasive mitral valve
surgery performed via a right lateral thoracotomy and
conventional mitral valve surgery performed via median
sternotomy. In contrast to the recent meta-analysis by
Cheng and colleagues,1 we did not find an increase in stroke
rate in the MIVS group. Mitral valve surgery via a right
lateral minithoracotomy seems to be favorable with regard
to resource-related outcomes.
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FIGURE E1. Forest and funnel plots for procedure time in minutes. MIV, Minimally invasive; Conv, conventional; SD, standard deviation; MD, mean
difference; CI, confidence interval; W, weight.
FIGURE E2. Forest and funnel plots for cardiopulmonary bypass time in minutes.MIV, Minimally invasive; Conv, conventional; SD, standard deviation;
MD, mean difference; CI, confidence interval; W, weight.
FIGURE E3. Forest and funnels plot for crossclamp time in minutes. MIV, Minimally invasive; Conv, conventional; SD, standard deviation; MD, mean
difference; CI, confidence interval; W, weight.
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FIGURE E4. Forest and funnel plots for blood drainage volume in milliliters. MIV, Minimally invasive; Conv, conventional; SD, standard deviation;
MD, mean difference; CI, confidence interval; W, weight.
FIGUREE5. Forest and funnel plots for the number of patients who needed blood transfusion.MIV, Minimally invasive;Conv, conventional; RR, risk ratio;
CI, confidence interval; W, weight.
FIGURE E6. Forest and funnel plots for length of stay in the intensive care unit in hours. MIV, Minimally invasive; Conv, conventional; SD, standard
deviation; MD, mean difference; CI, confidence interval; W, weight.
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FIGURE E7. Forest and funnel plots for length of respirator dependence time in hours. MIV, Minimally invasive; Conv, conventional; SD, standard
deviation; MD, mean difference; CI, confidence interval; W, weight.
FIGURE E8. Forest and funnel plots for length of hospital stay in days.MIV, Minimally invasive; Conv, conventional; SD, standard deviation;MD, mean
difference; CI, confidence interval; W, weight.
FIGURE E9. Forest and funnel plots for patients who needed a rethoracotomy for bleeding complications.MIV, Minimally invasive; Conv, conventional;
RR, risk ratio; CI, confidence interval; W, weight.
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FIGURE E10. Forest and funnel plots for new onset of atrial fibrillation. MIV, Minimally invasive; Conv, conventional; RR, risk ratio; CI, confidence
interval; W, weight.
FIGURE E11. Forest and funnel plots for new postoperative renal failure. MIV, Minimally invasive; Conv, conventional; RR, risk ratio; CI, confidence
interval; W, weight.
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